MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma.
Model: UVB irradiation of dorsal skin from Philips FS40 lamps: a single 2,240 J/m2 dose (1 minimal erythemic dose) for the acute study, and 1 minimal erythemic dose three times weekly on non-consecutive days for 10 weeks for the chronic carcinogenesis study
Pretreatment increased keratinocyte apoptosis and early p53 while reducing Ki67, cyclobutane pyrimidine dimers, phosphohistone H2A.X and myeloperoxidase. Chronically it reduced p53 foci density (p=0.0014), epidermal Ki67 (p=0.0168) and tumour burden at 18 weeks (p=0.0131), and no treated tumour pro…
Extraction: extract · Supplied extraction confidence: 0.95. Machine-extracted fields require source verification.